Dr. David E. Kozono
Claim this profileBrigham and Women's Hospital
Studies Lung Cancer
Studies Small Cell Lung Cancer
4 reported clinical trials
15 drugs studied
Area of expertise
1Lung Cancer
Stage IV
Stage II
Stage I
2Small Cell Lung Cancer
Stage I
Stage II
Stage IV
Affiliated Hospitals
Clinical Trials David E. Kozono is currently running
Radiation Therapy
for Neuroblastoma
This trial collects biological samples from children with specific cancers who are receiving radiation therapy. The goal is to understand how radiation affects both cancerous and normal cells, which can help improve future treatments.
Recruiting1 award N/A
MRI Monitoring vs. Preventive Brain Radiation
for Small Cell Lung Cancer
This phase III trial studies magnetic resonance imaging (MRI) surveillance and prophylactic cranial irradiation (PCI) to see how well they work compared to MRI surveillance alone in treating patients with small cell lung cancer. MRI scans are used to monitor the possible spread of the cancer with an MRI machine over time. PCI is radiation therapy that is delivered to the brain in hopes of preventing spread of cancer into the brain. The use of brain MRI alone may reduce side effects of receiving PCI and prolong patients' lifespan. Monitoring with MRI scans alone (delaying radiation until the actual spread of the cancer) may be at least as good as the combination of PCI with MRI scans.
Recruiting2 awards Phase 322 criteria
More about David E. Kozono
Clinical Trial Related6 years of experience running clinical trials · Led 4 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments David E. Kozono has experience with
- 131I-Metaiodobenzylguanidine (MIBG)
- External Beam Radiotherapy
- Docetaxel
- Erlotinib Hydrochloride
- Gemcitabine
- Local Consolidation Therapy
Breakdown of trials David E. Kozono has run
Lung Cancer
Small Cell Lung Cancer
Brain Tumor
Neuroblastoma
Childhood Brainstem Glioma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does David E. Kozono specialize in?
David E. Kozono focuses on Lung Cancer and Small Cell Lung Cancer. In particular, much of their work with Lung Cancer has involved Stage IV patients, or patients who are Stage II.
Is David E. Kozono currently recruiting for clinical trials?
Yes, David E. Kozono is currently recruiting for 2 clinical trials in Boston Massachusetts. If you're interested in participating, you should apply.
Are there any treatments that David E. Kozono has studied deeply?
Yes, David E. Kozono has studied treatments such as 131I-Metaiodobenzylguanidine (MIBG), External beam radiotherapy, Docetaxel.
What is the best way to schedule an appointment with David E. Kozono?
Apply for one of the trials that David E. Kozono is conducting.
What is the office address of David E. Kozono?
The office of David E. Kozono is located at: Brigham and Women's Hospital, Boston, Massachusetts 02115 United States. This is the address for their practice at the Brigham and Women's Hospital.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.